Total Payments
$5,345
2024 Payments
$278.75
Companies
7
Transactions
24
Medicare Patients
10,682
Medicare Billing
$1.3M
Payment Breakdown by Category
Consulting$3,500 (65.5%)
Food & Beverage$1,152 (21.6%)
Travel$692.79 (13.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,500 | 2 | 65.5% |
| Food and Beverage | $1,152 | 21 | 21.6% |
| Travel and Lodging | $692.79 | 1 | 13.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dutch Ophthalmic, USA | $4,223 | 6 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $523.48 | 2 | $0 (2019) |
| ABBVIE INC. | $234.09 | 11 | $0 (2024) |
| Genentech, Inc. | $180.39 | 2 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $99.99 | 1 | $0 (2023) |
| Carl Zeiss Meditec, Inc. | $69.76 | 1 | $0 (2019) |
| Allergan, Inc. | $14.38 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $278.75 | 8 | ABBVIE INC. ($141.35) |
| 2023 | $121.04 | 2 | Mallinckrodt Hospital Products Inc. ($99.99) |
| 2022 | $86.07 | 4 | ABBVIE INC. ($71.69) |
| 2021 | $174.07 | 1 | Dutch Ophthalmic, USA ($174.07) |
| 2019 | $662.44 | 4 | Novartis Pharmaceuticals Corporation ($523.48) |
| 2018 | $3,836 | 3 | Dutch Ophthalmic, USA ($3,836) |
| 2017 | $186.71 | 2 | Dutch Ophthalmic, USA ($143.72) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: EYE CARE | ||||||
| 11/21/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $137.40 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/21/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: EYE CARE | ||||||
| 10/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: EYE CARE | ||||||
| 08/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: EYE CARE | ||||||
| 05/09/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: EYE CARE | ||||||
| 03/26/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: EYE CARE | ||||||
| 02/22/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: EYE CARE | ||||||
| 03/18/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $99.99 | General |
| Category: IMMUNOLOGY | ||||||
| 01/19/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: EYE CARE | ||||||
| 12/15/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: RETINA | ||||||
| 12/08/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: RETINA | ||||||
| 10/27/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: RETINA | ||||||
| 03/31/2022 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: RETINA | ||||||
| 04/13/2021 | Dutch Ophthalmic, USA | EVA Ophthalmic Surgical System (Device) | Food and Beverage | In-kind items and services | $174.07 | General |
| Category: Ophthalmology | ||||||
| 07/29/2019 | Dutch Ophthalmic, USA | EVA Ophthalmic Surgical System (Device) | Food and Beverage | In-kind items and services | $69.20 | General |
| Category: Ophthalmology | ||||||
| 05/31/2019 | Carl Zeiss Meditec, Inc. | — | Food and Beverage | In-kind items and services | $69.76 | General |
| 05/21/2019 | Novartis Pharmaceuticals Corporation | BINIMETINIB (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/26/2018 | Dutch Ophthalmic, USA | EVA Ophthalmic Surgical System (Device) | Food and Beverage | In-kind items and services | $142.86 | General |
| Category: Ophthalmology | ||||||
| 05/31/2018 | Dutch Ophthalmic, USA | EVA Ophthalmic Surgical System (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Ophthalmology | ||||||
| 05/31/2018 | Dutch Ophthalmic, USA | EVA Ophthalmic Surgical System (Device) | Travel and Lodging | Cash or cash equivalent | $692.79 | General |
| Category: Ophthalmology | ||||||
| 11/11/2017 | Genentech, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $42.99 | General |
| Category: Ophthalmology | ||||||
| 11/10/2017 | Dutch Ophthalmic, USA | EVA Ophthalmic Surgical System (Device) | Food and Beverage | In-kind items and services | $143.72 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,357 | 4,958 | $4.0M | $474,344 |
| 2022 | 16 | 2,771 | 3,921 | $2.8M | $302,053 |
| 2021 | 16 | 2,494 | 3,453 | $2.4M | $270,579 |
| 2020 | 14 | 2,060 | 2,855 | $2.1M | $205,083 |
Total Patients
10,682
Total Services
15,187
Medicare Billing
$1.3M
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 727 | 1,065 | $1.0M | $154,753 | 15.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 22 | 148 | $616,420 | $102,026 | 16.6% |
| 92134 | Imaging of retina | Office | 2023 | 612 | 866 | $311,270 | $28,704 | 9.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 181 | 210 | $145,180 | $26,451 | 18.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 429 | 567 | $457,704 | $22,201 | 4.9% |
| 67218 | Destruction of growth of retina by implantation of radiation source | Facility | 2023 | 17 | 18 | $166,140 | $21,235 | 12.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 741 | 1,001 | $118,811 | $21,032 | 17.7% |
| 67028 | Injection of drug into eye | Facility | 2023 | 37 | 200 | $218,558 | $18,071 | 8.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 44 | 163 | $157,470 | $16,891 | 10.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 74 | 74 | $100,640 | $13,526 | 13.4% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 15 | 16 | $141,280 | $10,627 | 7.5% |
| 67121 | Removal of implant material from inside of eye | Facility | 2023 | 13 | 13 | $79,170 | $10,337 | 13.1% |
| 76510 | 1d and 2d ultrasound scan of eye tissue and structures | Office | 2023 | 109 | 147 | $209,300 | $8,102 | 3.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 22 | 93 | $23,250 | $6,559 | 28.2% |
| 92250 | Photography of the retina | Office | 2023 | 178 | 213 | $96,915 | $6,338 | 6.5% |
| 76513 | Ultrasound scan of eye using water bath method | Office | 2023 | 79 | 97 | $79,600 | $5,904 | 7.4% |
| 92285 | Photography of content of eyes | Office | 2023 | 44 | 54 | $13,284 | $966.75 | 7.3% |
| 67415 | Fine needle aspiration of orbital contents | Facility | 2023 | 13 | 13 | $9,035 | $619.76 | 6.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 612 | 924 | $887,040 | $136,526 | 15.4% |
| 67218 | Destruction of growth of retina by implantation of radiation source | Facility | 2022 | 23 | 24 | $221,520 | $29,205 | 13.2% |
| 92134 | Imaging of retina | Office | 2022 | 455 | 668 | $197,060 | $21,562 | 10.9% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 394 | 498 | $397,722 | $19,699 | 5.0% |
| 67028 | Injection of drug into eye | Facility | 2022 | 39 | 212 | $220,368 | $18,152 | 8.2% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 625 | 824 | $91,464 | $17,334 | 19.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 78 | 78 | $105,092 | $14,557 | 13.9% |
About Dr. Tara Mccannel, MD
Dr. Tara Mccannel, MD is a Ophthalmology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790707842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tara Mccannel, MD has received a total of $5,345 in payments from pharmaceutical and medical device companies, with $278.75 received in 2024. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($3,500).
As a Medicare-enrolled provider, Mccannel has provided services to 10,682 Medicare beneficiaries, totaling 15,187 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Los Angeles, CA
- Active Since 07/24/2006
- Last Updated 05/07/2013
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1790707842
Products in Payments
- EVA Ophthalmic Surgical System (Device) $4,223
- BINIMETINIB (Drug) $500.00
- OZURDEX (Drug) $248.47
- Vabysmo (Drug) $137.40
- ACTHAR (Biological) $99.99
- Lucentis (Biological) $42.99
- BEOVU (Drug) $23.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Los Angeles
Dr. Andrew Moshfeghi, Md, MD
Ophthalmology — Payments: $898,549
Ophthalmology $898,549
Dr. Barry Seibel, M.d, M.D
Ophthalmology — Payments: $893,403
Ophthalmology $893,403
Neda Shamie, M.d, M.D
Ophthalmology — Payments: $693,812
Ophthalmology $693,812
David Boyer, Md, MD
Ophthalmology — Payments: $514,544
Ophthalmology $514,544
David Hamilton, Od, OD
Ophthalmology — Payments: $477,856
Ophthalmology $477,856
Dr. Nicole Fram, Md, MD
Ophthalmology — Payments: $382,620
Ophthalmology $382,620